Unichem Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351A01035
  • NSEID: UNICHEMLAB
  • BSEID: 506690
INR
474.55
12.85 (2.78%)
BSENSE

Jul 01, 03:30 PM

BSE+NSE Vol: 2.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryUnichem Labs. VS Pharmaceuticals & Biotechnology
 
1D
2.78%
0.59%
1W
9.46%
-0.07%
1M
38.33%
2.67%
YTD
7.4%
-8.13%
1Y
-20.14%
-6.01%
3Y
26.68%
25.1%
5Y
44.59%
53.1%
10Y
66.89%
188.24%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
59.14%
0%
59.14%
6 Months
7.88%
0%
7.88%
1 Year
-20.14%
0%
-20.14%
2 Years
-10.57%
0%
-10.57%
3 Years
26.68%
0%
26.68%
4 Years
95.93%
1.33%
97.26%
5 Years
44.59%
1.18%
45.77%

Latest dividend: 4.018148210384809 per share ex-dividend date: Aug-01-2022

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available